Revolution Medicines' daraxonrasib appears in two new pancreatic cancer trial registrationsOct 27Weekly roundup, 2 itemsdaraxonrasibRevolution Medicines, Inc.
Synnovation registers Phase 1 trial of SNV1521 with Revolution Medicines' daraxonrasibAug 10Trial updatedaraxonrasibRevolution Medicines, Inc.